Review of lipid and lipoprotein(a) abnormalities in childhood arterial ischemic stroke

Sally M. Sultan, Nicole Schupf, Michael M. Dowling, Gabrielle A. Deveber, Adam Kirton, Mitchell S V Elkind

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

National organizations recommend cholesterol screening in children to prevent vascular disease in adulthood. There are currently no recommendations for cholesterol and lipoprotein (a) testing in children who experience an arterial ischemic stroke. While dyslipidemia and elevated lipoprotein (a) are associated with ischemic stroke in adults, the role of atherosclerotic risk factors in childhood arterial ischemic stroke is not known. A review of the literature was performed from 1966 to April 2012 to evaluate the association between childhood arterial ischemic stroke and dyslipidemia or elevated lipoprotein (a). Of 239 citations, there were 16 original observational studies in children (with or without neonates) with imaging-confirmed arterial ischemic stroke and data on cholesterol or lipoprotein (a) values. Three pairs of studies reported overlapping subjects, and two were eliminated. Among 14 studies, there were data on cholesterol in 7 and lipoprotein (a) in 10. After stroke, testing was performed at >three-months in nine studies, at ≤three-months in four studies, and not specified in one study. There were five case-control studies: four compared elevated lipoprotein (a) and one compared abnormal cholesterol in children with arterial ischemic stroke to controls. A consistent positive association between elevated lipoprotein (a) and stroke was found [Mantel-Haenszel OR 4·24 (2·94-6·11)]. There was no association in one study on total cholesterol, and a positive association in one study on triglycerides. The literature suggests that elevated lipoprotein (a) may be more likely in children with arterial ischemic stroke than in control children. The absence of confirmatory study on dyslipidemia should be addressed with future research.

Original languageEnglish (US)
Pages (from-to)79-87
Number of pages9
JournalInternational Journal of Stroke
Volume9
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Lipoprotein(a)
Stroke
Lipids
Cholesterol
Dyslipidemias
Vascular Diseases
Observational Studies
Case-Control Studies
Triglycerides
Newborn Infant

Keywords

  • Atherosclerosis
  • Childhood stroke
  • Cholesterol
  • Lipid
  • Lipoprotein(a)
  • Risk factor

ASJC Scopus subject areas

  • Neurology

Cite this

Review of lipid and lipoprotein(a) abnormalities in childhood arterial ischemic stroke. / Sultan, Sally M.; Schupf, Nicole; Dowling, Michael M.; Deveber, Gabrielle A.; Kirton, Adam; Elkind, Mitchell S V.

In: International Journal of Stroke, Vol. 9, No. 1, 01.2014, p. 79-87.

Research output: Contribution to journalArticle

Sultan, Sally M. ; Schupf, Nicole ; Dowling, Michael M. ; Deveber, Gabrielle A. ; Kirton, Adam ; Elkind, Mitchell S V. / Review of lipid and lipoprotein(a) abnormalities in childhood arterial ischemic stroke. In: International Journal of Stroke. 2014 ; Vol. 9, No. 1. pp. 79-87.
@article{7202fec36803473fb10217bc694b5a36,
title = "Review of lipid and lipoprotein(a) abnormalities in childhood arterial ischemic stroke",
abstract = "National organizations recommend cholesterol screening in children to prevent vascular disease in adulthood. There are currently no recommendations for cholesterol and lipoprotein (a) testing in children who experience an arterial ischemic stroke. While dyslipidemia and elevated lipoprotein (a) are associated with ischemic stroke in adults, the role of atherosclerotic risk factors in childhood arterial ischemic stroke is not known. A review of the literature was performed from 1966 to April 2012 to evaluate the association between childhood arterial ischemic stroke and dyslipidemia or elevated lipoprotein (a). Of 239 citations, there were 16 original observational studies in children (with or without neonates) with imaging-confirmed arterial ischemic stroke and data on cholesterol or lipoprotein (a) values. Three pairs of studies reported overlapping subjects, and two were eliminated. Among 14 studies, there were data on cholesterol in 7 and lipoprotein (a) in 10. After stroke, testing was performed at >three-months in nine studies, at ≤three-months in four studies, and not specified in one study. There were five case-control studies: four compared elevated lipoprotein (a) and one compared abnormal cholesterol in children with arterial ischemic stroke to controls. A consistent positive association between elevated lipoprotein (a) and stroke was found [Mantel-Haenszel OR 4·24 (2·94-6·11)]. There was no association in one study on total cholesterol, and a positive association in one study on triglycerides. The literature suggests that elevated lipoprotein (a) may be more likely in children with arterial ischemic stroke than in control children. The absence of confirmatory study on dyslipidemia should be addressed with future research.",
keywords = "Atherosclerosis, Childhood stroke, Cholesterol, Lipid, Lipoprotein(a), Risk factor",
author = "Sultan, {Sally M.} and Nicole Schupf and Dowling, {Michael M.} and Deveber, {Gabrielle A.} and Adam Kirton and Elkind, {Mitchell S V}",
year = "2014",
month = "1",
doi = "10.1111/ijs.12136",
language = "English (US)",
volume = "9",
pages = "79--87",
journal = "International Journal of Stroke",
issn = "1747-4930",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Review of lipid and lipoprotein(a) abnormalities in childhood arterial ischemic stroke

AU - Sultan, Sally M.

AU - Schupf, Nicole

AU - Dowling, Michael M.

AU - Deveber, Gabrielle A.

AU - Kirton, Adam

AU - Elkind, Mitchell S V

PY - 2014/1

Y1 - 2014/1

N2 - National organizations recommend cholesterol screening in children to prevent vascular disease in adulthood. There are currently no recommendations for cholesterol and lipoprotein (a) testing in children who experience an arterial ischemic stroke. While dyslipidemia and elevated lipoprotein (a) are associated with ischemic stroke in adults, the role of atherosclerotic risk factors in childhood arterial ischemic stroke is not known. A review of the literature was performed from 1966 to April 2012 to evaluate the association between childhood arterial ischemic stroke and dyslipidemia or elevated lipoprotein (a). Of 239 citations, there were 16 original observational studies in children (with or without neonates) with imaging-confirmed arterial ischemic stroke and data on cholesterol or lipoprotein (a) values. Three pairs of studies reported overlapping subjects, and two were eliminated. Among 14 studies, there were data on cholesterol in 7 and lipoprotein (a) in 10. After stroke, testing was performed at >three-months in nine studies, at ≤three-months in four studies, and not specified in one study. There were five case-control studies: four compared elevated lipoprotein (a) and one compared abnormal cholesterol in children with arterial ischemic stroke to controls. A consistent positive association between elevated lipoprotein (a) and stroke was found [Mantel-Haenszel OR 4·24 (2·94-6·11)]. There was no association in one study on total cholesterol, and a positive association in one study on triglycerides. The literature suggests that elevated lipoprotein (a) may be more likely in children with arterial ischemic stroke than in control children. The absence of confirmatory study on dyslipidemia should be addressed with future research.

AB - National organizations recommend cholesterol screening in children to prevent vascular disease in adulthood. There are currently no recommendations for cholesterol and lipoprotein (a) testing in children who experience an arterial ischemic stroke. While dyslipidemia and elevated lipoprotein (a) are associated with ischemic stroke in adults, the role of atherosclerotic risk factors in childhood arterial ischemic stroke is not known. A review of the literature was performed from 1966 to April 2012 to evaluate the association between childhood arterial ischemic stroke and dyslipidemia or elevated lipoprotein (a). Of 239 citations, there were 16 original observational studies in children (with or without neonates) with imaging-confirmed arterial ischemic stroke and data on cholesterol or lipoprotein (a) values. Three pairs of studies reported overlapping subjects, and two were eliminated. Among 14 studies, there were data on cholesterol in 7 and lipoprotein (a) in 10. After stroke, testing was performed at >three-months in nine studies, at ≤three-months in four studies, and not specified in one study. There were five case-control studies: four compared elevated lipoprotein (a) and one compared abnormal cholesterol in children with arterial ischemic stroke to controls. A consistent positive association between elevated lipoprotein (a) and stroke was found [Mantel-Haenszel OR 4·24 (2·94-6·11)]. There was no association in one study on total cholesterol, and a positive association in one study on triglycerides. The literature suggests that elevated lipoprotein (a) may be more likely in children with arterial ischemic stroke than in control children. The absence of confirmatory study on dyslipidemia should be addressed with future research.

KW - Atherosclerosis

KW - Childhood stroke

KW - Cholesterol

KW - Lipid

KW - Lipoprotein(a)

KW - Risk factor

UR - http://www.scopus.com/inward/record.url?scp=84890856783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890856783&partnerID=8YFLogxK

U2 - 10.1111/ijs.12136

DO - 10.1111/ijs.12136

M3 - Article

C2 - 24148253

AN - SCOPUS:84890856783

VL - 9

SP - 79

EP - 87

JO - International Journal of Stroke

JF - International Journal of Stroke

SN - 1747-4930

IS - 1

ER -